Effectiveness of Extracorporeal Shockwave in Planter Fasciitis
2026年7月3日 更新者：Adly A Adam
Effectiveness of Extracorporeal Shockwave on Gait Parameters and Quality of Life in Planter Fasciitis
Extracorporeal Shockwave (ESW) is a popular, non-invasive approach that arisen in line to stimulate healing via acoustic waves targeting lesion site i.e., planter fasciitis.
Therefore, current clinical trial targets to determine the long-term effectiveness of ESW on Calcaneal spur in terms of quality of life, functional, and clinical manifestations, as well addressing real barriers for ESW approach among whom diagnosed with planter fasciitis.
調査の概要
状態
完了
詳細な説明
Worldwide ESW protocol parameters' discrepancy still a research gap, mainly in terms of calcaneal spur i.e., sessions' number, applications' parameters.
Therefore, current clinical trial was conducted to address the effectiveness of ESW on planter fasciitis on long-term, plus identifying the real barriers addressed by sufferers.
研究の種類
観察的
入学 (実際)
175
連絡先と場所
このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。
研究場所
-
-
Menofyia
-
Cairo、Menofyia、エジプト、11432
- Al-Kasr Al-Ani Hospitals
-
-
参加基準
研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。
適格基準
就学可能な年齢
- 大人
健康ボランティアの受け入れ
いいえ
サンプリング方法
確率サンプル
調査対象母集団
Current observational cohort trial involved participants diagnosed with planter fasciitis, whom age ranged between 25-59 years old, with nearby 3 months of clinical manifestations mainly heel pain.
They had plantar medial heel pain: most noticeable with initial steps after a period of inactivity, but also worse following prolonged weight-bearing,
- Whom had pain with palpation of the proximal insertion of the plantar fascia.
- Whom had positive windlass test.
説明
Inclusion Criteria:
- Individuals diagnosed with planter fasciitis, whom age ranged between 25-59 years old, with nearby 3 months of clinical manifestations mainly heel pain.
- Whom have plantar medial heel pain: most noticeable with initial steps after a period of inactivity, but also worse following prolonged weight-bearing,
- Whom had pain with palpation of the proximal insertion of the plantar fascia.
- Whom had positive windlass test.
Exclusion Criteria:
- Any individual whom underwent feet or ankle surgical interventions, received steroid injections within the past 3 months, also whom have deep venous thrombosis, or had a tarsal tunnel syndrome, diabetic neuropathies or any sort of tumors, lymphatic lesions.
研究計画
このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。
研究はどのように設計されていますか？
デザインの詳細
コホートと介入
グループ/コホート |
|---|
|
Experimental Group
A 150 individuals with planter fasciitis whom received ESW intervention.
Their age ranged between 25 to 59 years old, with well-organized full demographic data filling system, and evaluation for their clinical manifestations, plus service quality evaluation in line to address the long-term effectiveness of the received ESW therapeutic protocol, and identifying barriers they addressed.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Pressure Pain Threshold
時間枠：1- At Baseline, 2- Post-Treatment, 3- After 6 months as long-term follow-up
|
A valid, reliable Pressure Algometer device, that is calibrated per each evaluation, in line to identify well-addressed pressure pain threshold, that spread from the plantar calcaneal tuberosity for each participant.
|
1- At Baseline, 2- Post-Treatment, 3- After 6 months as long-term follow-up
|
|
American Orthopedic Foot and Ankle Society Scale (AOFAS)
時間枠：1- At baseline, 2- Post-treatment, 3- After 6 months as long-term follow-up.
|
a 9-item questionnaire classified into three subscales: 1) level of pain consists of 1 item and its score ranges from 0 to 40; 40 points = no pain and 0 points = severe pain; 2) function consists of 7 items (Activity limitations, support requirements, maximum continuous walking distance, walking surface, gait abnormalities, sagittal motion, hind foot motion, ankle hind-foot stability), and its score ranges from 0 (severe function impairment score) to 50 points (full function score); and 3) foot alignment consists of 1 item; its score ranges from 0 to 10 points; good alignment of ankle and foot equals 10 points and zero indicates severe malalignment, symptoms.
It was used for measuring functional recovery after different foot and ankle problems.
The total score of the scale ranged from 0 to 100 points; (0) indicates the worst, and (100) shows no symptoms or impairments.
|
1- At baseline, 2- Post-treatment, 3- After 6 months as long-term follow-up.
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Visual Analogue Scale
時間枠：1- At Baseline, 2- Post-Treatment, 3- After 6 months as long-term follow-up
|
10-point, as 0 (no pain) to 10 (worst pain they can imagine). VAS scores ≤3.4 demarcated as mild pain, 3.5 to 7.4 as moderate pain, and ≥7.5 as severe pain. VAS is a simple, valid, as well as successful way to keep monitor of how a patient's pain is changing over time, and it has been utilized extensively in varied adult groups with a strong evidence of test-retest reliability (ICC= 0.99, 95%CI 0.989-0.992) |
1- At Baseline, 2- Post-Treatment, 3- After 6 months as long-term follow-up
|
|
Arabic version of the foot function index (FFI)
時間枠：1- At Baseline, 2- Post-Treatment, 3- After 6 months as long-term follow-up
|
a widely used self-reporting measure used to assess the impact of foot pathology on pain, disability, and activity limitation.
It is a reliable and sensitive outcome measure for patients with foot and ankle disorders.
The FFI's subscale scores range from 0% to 100%, with higher scores indicating lower function and a poorer quality of life
|
1- At Baseline, 2- Post-Treatment, 3- After 6 months as long-term follow-up
|
協力者と研究者
ここでは、この調査に関係する人々や組織を見つけることができます。
スポンサー
捜査官
- 主任研究者：Adnan AA Gharib、GOTHI
研究記録日
これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。
主要日程の研究
研究開始 (実際)
2024年4月1日
一次修了 (実際)
2026年1月1日
研究の完了 (実際)
2026年5月30日
試験登録日
最初に提出
2026年6月21日
QC基準を満たした最初の提出物
2026年6月21日
最初の投稿 (実際)
2026年6月25日
学習記録の更新
投稿された最後の更新 (実際)
2026年7月7日
QC基準を満たした最後の更新が送信されました
2026年7月3日
最終確認日
2026年7月1日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。